Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection

Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide; however, accurate prognostic tools are still lacking. We aimed to identify immunohistochemistry (IHC)-based signature as a prognostic classifier to predict recurrence and survival in patients with HCC at Barcelona Clinic Liver...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Bai, Yannan, Lian, Yuane, Chen, Xiaoping, Wu, Jiayi, Lai, Jianlin, Qiu, Funan, Zhou, Songqiang, Zhu, Zijing, Tian, Yifeng, Wang, Yaodong, Yang, Yinghong, Yan, Maolin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7874098/
https://ncbi.nlm.nih.gov/pubmed/33585243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.616263
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi